Nuvectra® to Participate in Two Upcoming Investor Conferences

PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation NVTR, a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY.

Webcasts of the Company's presentations will be available by visiting the investor relations section of Nuvectra's website at www.nuvectramed.com. Webcast replays of the presentations will be available for 90 days.

About Nuvectra Corporation

Nuvectra^® is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita^® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson's Disease. Visit the Nuvectra website at www.nuvectramed.com.